HIGHLIGHTS
- who: Nouf Alluqmani and colleagues from the University of Tabuk, Saudi Arabia have published the research: Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines, in the Journal: (JOURNAL)
- what: This study provides a new framework for understanding the immunological impacts of vanadium-VSV combinations, and provide a path forward for therapeutic regimen optimization, exemplified by the combination of VS and VSVD51-IL12.
- how: Data were analyzed using Prism. frontiersin.org 10.3389/fimmu.2022.1032356 guidelines for animal care under . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.